SOX18 and Kaposi's sarcoma: Moreover, Sm4 also significantly decreased the infected spindle cell phenotype (hallmark of KSHV infection) and relative KSHV genome copies in vivo (Tuohinto et al., 2023), suggesting SOX18 as an attractive therapeutic target for KS.